Project Grant HT94252510991
- The U.S. Defense Health Agency awarded a $616,150 Project Grant to The Johns Hopkins University to support the "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE" under the Military Medical Research and Development program (CFDA 12.420). The project aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public by developing...
- The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
- This Project Grant award of $320,165.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research at The Johns Hopkins University focused on the social determinants of health, biological aging, and disease course in multiple sclerosis. The project aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to critical health challenges. As a leading...
- The Defense Health Agency awarded The Johns Hopkins University a $818,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Immune System Disturbances After Borrelia Burgdorferi Infection". The project will take place over 3 years from August 1, 2023 to July 31, 2026. As a leading research university, Johns Hopkins has extensive experience providing biomedical research, public health initiatives, and scientific analysis to...
- This $318,483 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports quantitative measurement of acute and chronic lesion activity in a real-world multisite clinical MRI dataset at The Johns Hopkins University. The research aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The award period runs from August 1, 2025 to July 31, 2027. As a...
- The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
- The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
- The Department of Defense's Defense Health Agency awarded a $798,272 Project Grant to The Johns Hopkins University on March 15, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project to test the use of Wnt inhibitors as a potential therapeutic intervention to reverse TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS). As a leading research institution, The Johns Hopkins University has a strong track record of...
- This $319,240 Project Grant was awarded on September 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The funding supports research to characterize the microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This basic and applied biomedical research aims to transform healthcare for military service members, veterans, and the broader public by advancing scientific...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
The Defense Health Agency awarded a $1,407,634.00 Project Grant to The Johns Hopkins University on September 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE," will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The Johns Hopkins University, a leading federal contractor and grantee, will leverage its expertise across biomedical research, medical innovation, and scientific consultation to conduct the proposed investigations over a 3-year performance period ending on August 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.4m | 8/25/25 |